Nonsteroidal Mineralocorticoid-Receptor Antagonist
- Name
- Nonsteroidal Mineralocorticoid-Receptor Antagonist
- Accession Number
- DBCAT005529
- Description
Not Available
- Drugs
Drug Drug Description Finerenone A nonsteroidal mineralocorticoid receptor antagonist indicated to lower the risk of eGFR decline, end stage kidney disease, cardiovascular death, heart attack, and hospitalization for heart failure in chronic kidney disease associated with type 2 diabetes. - Drugs & Drug Targets
Drug Target Type Finerenone Cytochrome P450 3A4 enzyme Finerenone Cytochrome P450 2C8 enzyme Finerenone Serum albumin carrier Finerenone Mineralocorticoid receptor target Finerenone Cytochrome P450 1A1 enzyme